Earlier studies demonstrated that up to 60% of sporadic meningiomas exhibit biallelic Neurofibromin 2 (NF2) gene inactivation due to chromosome 22 monosomy with concurrent NF2 point mutations (NF2 meningiomas/tumors) (3, 4). This evidence concerns the gene NF2 and meningioma.